Podoplanin expression in advanced atherosclerotic lesions of human aortas

Thrombosis Research

Volumn 129, Issue 4, 2012, Pages

  Hatakeyama, Kinta ^a,b   Kaneko, Mika Kato ^b   Kato, Yukinari ^b   Ishikawa, Tetsunori ^a   Nishihira, Kensaku ^c   Tsujimoto, Yuta ^b   Shibata, Yoshisato ^c   Ozaki, Yukio ^d   Asada, Yujiro ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c Miyazaki Medical Association Hospital   (Japan)

^d UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

atherosclerosis; macrophages; podoplanin; smooth muscle cells; thrombus formation

Indexed keywords

PODOPLANIN;

ABDOMINAL AORTA; ADULT; ADVANCED AORTA ATHEROSCLEROSIS; AGED; AORTA ATHEROSCLEROSIS; ARTICLE; AUTOPSY; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

ADOLESCENT; ADULT; AORTA, ABDOMINAL; AORTIC DISEASES; ATHEROSCLEROSIS; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; TISSUE DISTRIBUTION; YOUNG ADULT;

EID: 84863396918     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.01.003     Document Type: Article

References (33)

1. M.J. Davies A macro and micro view of coronary vascular insult in ischemic heart disease Circulation 82 1990 II38 II46
2. Z.M. Ruggeri von Willebrand factor J Clin Invest 99 1997 559 564
3. Y. Kato, N. Fujita, A. Kunita, S. Sato, M. Kaneko, and M. Osawa Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors J Biol Chem 278 2003 51599 51605
4. K. Suzuki-Inoue, Y. Kato, O. Inoue, M.K. Kaneko, K. Mishima, and Y. Yatomi Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells J Biol Chem 282 2007 25993 26001
5. S. Breiteneder-Geleff, K. Matsui, A. Soleiman, P. Meraner, H. Poczewski, and R. Kalt Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis Am J Pathol 151 1997 1141 1152
6. Y. Kato, M. Kaneko, M. Sata, N. Fujita, T. Tsuruo, and M. Osawa Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma Tumor Biol 26 2005 195 200
7. Y. Kato, I. Sasagawa, M. Kaneko, M. Osawa, N. Fujita, and T. Tsuruo Aggrus: A diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors Oncogene 23 2004 8552 8556
8. Y. Kato, M.K. Kaneko, A. Kuno, N. Uchiyama, K. Amano, and Y. Chiba Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain Biochem Biophys Res Commun 349 2006 1301 1307
9. N. Kimura, and I. Kimura Podoplanin as a marker for mesothelioma Pathol Int 55 2005 83 86
10. K. Mishima, Y. Kato, M.K. Kaneko, Y. Nakazawa, A. Kunita, and N. Fujita Podoplanin expression in primary central nervous system germ cell tumors: a useful histological marker for the diagnosis of germinoma Acta Neuropathol (Berl) 111 2006 563 568
11. K. Mishima, Y. Kato, M.K. Kaneko, R. Nishikawa, T. Hirose, and M. Matsutani Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression Acta Neuropathol (Berl) 111 2006 483 488
12. H. Suzuki, Y. Kato, M.K. Kaneko, Y. Okita, H. Narimatsu, and M. Kato Induction of podoplanin by transforming growth factor-beta in human fibrosarcoma FEBS Lett 582 2008 341 345
13. A. Kunita, T.G. Kashima, A. Ohazama, A.E. Grigoriadis, and M. Fukayama Podoplanin is regulated by AP-1 and promotes platelet aggregation and cell migration in osteosarcoma Am J Pathol 179 2011 1041 1049
14. A. Wicki, F. Lehembre, N. Wick, B. Hantusch, D. Kerjaschki, and G. Christofori Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton Cancer Cell 9 2006 261 272
15. E. Martin-Villar, D. Megias, S. Castel, M.M. Yurrita, S. Vilaro, and M. Quintanilla Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition J Cell Sci 119 2006 4541 4553
16. A. Kunita, T.G. Kashima, Y. Morishita, M. Fukayama, Y. Kato, and T. Tsuruo The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis Am J Pathol 170 2007 1337 1347
17. Y. Kato, M.K. Kaneko, A. Kunita, H. Ito, A. Kameyama, and S. Ogasawara Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2 Cancer Sci 99 2008 54 61
18. H. Kawaguchi, A.K. El-Naggar, V. Papadimitrakopoulou, H. Ren, Y.H. Fan, and L. Feng Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy J Clin Oncol 26 2008 354 360
19. P. Yuan, S. Temam, A. El-Naggar, X. Zhou, D. Liu, and J. Lee Overexpression of podoplanin in oral cancer and its association with poor clinical outcome Cancer 107 2006 563 569
20. A. Hoshino, G. Ishii, T. Ito, K. Aoyagi, Y. Ohtaki, and K. Nagai Podoplanin-positive fibroblasts enhance lung adenocarcinoma tumor formation: podoplanin in fibroblast functions for tumor progression Cancer Res 71 2011 4769 4779
21. S. Ogasawara, M.K. Kaneko, J.E. Price, and Y. Kato Characterization of anti-podoplanin monoclonal antibodies: critical epitopes for neutralizing the interaction between podoplanin and CLEC-2 Hybridoma 27 2008 259 267
22. Y. Kato, G. Vaidyanathan, M.K. Kaneko, K. Mishima, N. Srivastava, and V. Chandramohan Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas Nucl Med Biol 37 2010 785 794
23. K. Hatakeyama, Y. Asada, K. Marutsuka, Y. Sato, Y. Kamikubo, and A. Sumiyoshi Localization and activity of tissue factor in human aortic atherosclerotic lesions Atherosclerosis 133 1997 213 219
24. T. Ishikawa, K. Hatakeyama, T. Imamura, K. Ito, S. Hara, and H. Date Increased adrenomedullin immunoreactivity and mRNA expression in coronary plaques obtained from patients with unstable angina Heart 9 2004 1206 1210
25. H.C. Stary, A.B. Chandler, R.E. Dinsmore, V. Fuster, S. Glagov, and W. Insull Jr. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis Circulation 92 1995 1355 1374
26. A. Yamashita, T. Sumi, S. Goto, Y. Hoshiba, K. Nishihira, and R. Kawamoto Detection of von Willebrand factor and tissue factor in platelets-fibrin rich coronary thrombi in acute myocardial infarction Am J Cardiol 97 2006 26 28
27. Y. Nakazawa, S. Takagi, S. Sato, T. Oh-hara, S. Koike, and M. Takami Prevention of hematogenous metastasis by neutralizing mice and its chimeric anti-Aggrus/podoplanin antibodies Cancer Sci 102 2011 2051 2057
28. M. Kaneko, Y. Kato, A. Kunita, N. Fujita, T. Tsuruo, and M. Osawa Functional sialylated O-glycan to platelet aggregation on Aggrus (T1alpha/podoplanin) molecules expressed in Chinese Hamster Ovary cells J Biol Chem 279 2004 38838 38843
29. M.K. Kaneko, Y. Kato, A. Kameyama, H. Ito, A. Kuno, and J. Hirabayashi Functional glycosylation of human podoplanin: glycan structure of platelet aggregation-inducing factor FEBS Lett 581 2007 331 336
30. S. Katsuda, Y. Okada, T. Minamoto, T. Oda, Y. Matsui, and I. Nakanishi Collagens in human atherosclerosis. Immunohistochemical analysis using collagen type-specific antibodies. Arterioscler Thromb 12 1992 494 502
31. K. Hatakeyama, H. Hao, T. Imamura, T. Ishikawa, Y. Shibata, and Y. Fujimura Relation of CD39 to plaque instability and thrombus formation in directional atherectomy specimens from patients with stable and unstable angina pectoris. Am J Cardiol 95 2005 632 635
32. A. Kawase, G. Ishii, K. Nagai, T. Ito, T. Nagano, and Y. Murata Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma. Int J Cancer 123 2008 1053 1059
33. M. Groger, R. Loewe, W. Holnthoner, R. Embacher, M. Pillinger, and G.S. Herron IL-3 induces expression of lymphatic markers Prox-1 and podoplanin in human endothelial cells J Immunol 173 2004 7161 7169